Acute kidney injury after out of hospital pediatric cardiac arrest
- PMID: 30075198
- PMCID: PMC6544025
- DOI: 10.1016/j.resuscitation.2018.07.362
Acute kidney injury after out of hospital pediatric cardiac arrest
Abstract
Importance: Many children with return of spontaneous circulation (ROSC) following cardiac arrest (CA) experience acute kidney injury (AKI). The impact of therapeutic hypothermia on the epidemiology of post-CA AKI in children has not been fully investigated.
Objective: The study aims were to: 1) describe the prevalence of severe AKI in comatose children following out-of-hospital CA (OHCA), 2) identify risk factors for severe AKI, 3) evaluate the impact of therapeutic hypothermia on the prevalence of severe AKI, and 4) evaluate the association of severe AKI with survival and functional outcomes.
Design: A post hoc secondary analysis of data from the Therapeutic Hypothermia after Pediatric Cardiac Arrest Out-of-Hospital (THAPCA-OH) trial.
Setting: Thirty-six pediatric intensive care units in the United States and Canada.
Participants: Of 282 eligible subjects with an initial creatinine obtained within 24 h of randomization, 148 were randomized to therapeutic hypothermia and 134 were randomized to therapeutic normothermia.
Main outcomes and measures: Primary outcome was prevalence of severe AKI, as defined by stage 2 and 3 Kidney Disease Improving Global Outcomes (KDIGO) consensus definition; secondary outcome was survival with a favorable neurobehavioral outcome. For this study, risk factors and outcomes were compared between those with/without severe AKI.
Results: Of the 282 subjects enrolled, 180 (64%) developed AKI of which 117 (41% of all enrolled) developed severe AKI. Multivariable modeling found younger age, longer duration of chest compressions, higher lactate level at time of temperature intervention and higher number of vasoactive agents through day 1 of intervention associated with severe AKI. There was no difference in severe AKI between therapeutic hypothermia (39.9%) and therapeutic normothermia (43.3%) groups (p = 0.629). Survival was lower in those with severe AKI at 28 days (21% vs no severe AKI 49%, p < 0.001) and 12 months (21% vs no severe AKI 42%, p < 0.001). One year survival with favorable functional outcome was lower in those with severe AKI.
Conclusions and relevance: Severe AKI occurs frequently in children with ROSC after OHCA, especially in younger children and those with higher initial lactates and hemodynamic support. Severe AKI was associated with worse survival and functional outcome. Therapeutic hypothermia did not reduce the incidence of severe AKI.
Keywords: Acute kidney injury; Neurologic outcomes; Post-cardiac arrest; Therapeutic hypothermia.
Copyright © 2018 Elsevier B.V. All rights reserved.
Figures
References
-
- Neumar RW, Nolan JP, Adrie C, Aibiki M, Berg RA, Böttiger BW, et al. Post-cardiac arrest syndrome: epidemiology, pathophysiology, treatment, and prognostication. A consensus statement from the International Liaison Committee on Resuscitation (American Heart Association, Australian and New Zealand Council on Resuscitation, European Resuscitation Council, Heart and Stroke Foundation of Canada, InterAmerican Heart Foundation, Resuscitation Council of Asia, and the Resuscitation Council of Southern Africa); the American Heart Association Emergency Cardiovascular Care Committee; the Council on Cardiovascular Surgery and Anesthesia; the Council on Cardiopulmonary, Perioperative, and Critical Care; the Council on Clinical Cardiology; and the Stroke Council. Circulation 2008;118:2452–83. doi:10.1161/CIRCULATIONAHA.108.190652. - DOI - PubMed
Publication types
MeSH terms
Grants and funding
- UL1 TR000433/TR/NCATS NIH HHS/United States
- R21 HD044955/HD/NICHD NIH HHS/United States
- R34 HD050531/HD/NICHD NIH HHS/United States
- P30 HD040677/HD/NICHD NIH HHS/United States
- K23 NS075363/NS/NINDS NIH HHS/United States
- U10 HD049981/HD/NICHD NIH HHS/United States
- U10 HD050096/HD/NICHD NIH HHS/United States
- UL1 TR000003/TR/NCATS NIH HHS/United States
- R01 DK103608/DK/NIDDK NIH HHS/United States
- UL1 RR024986/RR/NCRR NIH HHS/United States
- U01 HL094339/HL/NHLBI NIH HHS/United States
- U10 HD050012/HD/NICHD NIH HHS/United States
- R01 HL119542/HL/NHLBI NIH HHS/United States
- U10 HD049945/HD/NICHD NIH HHS/United States
- U01 HL094345/HL/NHLBI NIH HHS/United States
- U10 HD049983/HD/NICHD NIH HHS/United States
- UL1 TR002240/TR/NCATS NIH HHS/United States
- U10 HD050009/HD/NICHD NIH HHS/United States
- R01 FD005092/FD/FDA HHS/United States
- U01 HD049934/HD/NICHD NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
